UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
Using supercomputers, scientists have developed for the first time a way to screen drugs through their chemical structures for induced arrhythmias.
Ruth S. Waterman, MD, has been named chair of the Department of Anesthesiology at University of California San Diego School of Medicine and UC San Diego Health.
Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.
With website, UC San Diego School of Medicine scientists will monitor health and well-being during and after pandemic.
The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.
UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.
UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.